1McBride WG.Thalidomide and congenital abnormalities[J].Lancet,1961,(2):1358.
2Lazarou J,Pomeranz BH,Corey PN.Incidence of adverse drug reactions in hospitalized patients:a meta-analysis of prospective studies[J].JAMA,1998,279(15):1200-1205.
3White TJ,Arakelian A,Rho JP.Counting the costs of drug-related adverse events[J].Pharmacoeconomics,1999,15(5):445-458.
4Philips K.An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics[J].Pharmacogenomics,2003,4(3):231-239.